ArticleFrontiers in immunology2025

CDK2 inhibition sensitizes anthracycline-induced immunogenic cell death and enhances the efficacy of anti-PD-1 therapy.

Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.